Thrombocytopenia News and Research

RSS
Thrombocytopenia is a condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
CNIO researchers link MASTL protein to origin of thrombocytopenia

CNIO researchers link MASTL protein to origin of thrombocytopenia

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Study suggests new approach to treat life-threatening blood disorder in children

Study suggests new approach to treat life-threatening blood disorder in children

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

Researchers discuss clinical application of bivalirudin in interventional cardiovascular procedures

Researchers discuss clinical application of bivalirudin in interventional cardiovascular procedures

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Scripps Research scientists uncover new approach for treating thrombocytopenia

Scripps Research scientists uncover new approach for treating thrombocytopenia

FDA approves first therapy for patients with rare tumors of the adrenal gland

FDA approves first therapy for patients with rare tumors of the adrenal gland

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer announces FDA approval of biosimilar to Neupogen

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

Mystery 'disease X' warnings from WHO

Mystery 'disease X' warnings from WHO